Index -
P/E -
EPS (ttm) -27.79
Insider Own 13.79%
Shs Outstand 66.70M
Perf Week -0.30%
Market Cap 2.92B
Forward P/E 14.30
EPS next Y 3.04
Insider Trans -31.17%
Shs Float 57.96M
Perf Month 9.75%
Income -1859.40M
PEG -
EPS next Q 0.33
Inst Own 84.87%
Short Float 6.86%
Perf Quarter 2.04%
Sales 2.83B
P/S 1.03
EPS this Y -56.96%
Inst Trans 0.56%
Short Ratio 3.37
Perf Half Y -2.86%
Book/sh 47.30
P/B 0.92
EPS next Y 70.92%
ROA -24.40%
Short Interest 3.97M
Perf Year -44.14%
Cash/sh 1.59
P/C 27.30
EPS next 5Y 7.20%
ROE -45.48%
52W Range 29.74 - 79.96
Perf YTD -41.04%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -33.45%
52W High -45.66%
Beta 0.07
Dividend TTM -
Quick Ratio 0.79
Sales past 5Y 59.83%
Gross Margin 40.45%
52W Low 46.12%
ATR (14) 1.75
Dividend Ex-Date -
Current Ratio 1.44
EPS Y/Y TTM -4184.55%
Oper. Margin 3.46%
RSI (14) 55.22
Volatility 4.88% 3.66%
Employees 7100
Debt/Eq 0.87
Sales Y/Y TTM -10.37%
Profit Margin -65.72%
Recom 2.12
Target Price 54.00
Option/Short Yes / Yes
LT Debt/Eq 0.75
EPS Q/Q -176.39%
Payout -
Rel Volume 0.55
Prev Close 44.50
Sales Surprise 3.83%
EPS Surprise 69.97%
Sales Q/Q -4.07%
Earnings Jul 31 AMC
Avg Volume 1.18M
Price 43.45
SMA20 0.52%
SMA50 12.96%
SMA200 -12.99%
Trades
Volume 651,086
Change -2.36%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-05-24 Upgrade
Craig Hallum
Hold → Buy
$40 → $57
Mar-04-24 Downgrade
UBS
Neutral → Sell
$70 → $42
Feb-14-24 Downgrade
JP Morgan
Neutral → Underweight
$66 → $37
Dec-11-23 Downgrade
Citigroup
Buy → Neutral
$95 → $72
Dec-12-22 Upgrade
Citigroup
Neutral → Buy
$90 → $125
Dec-07-22 Initiated
RBC Capital Mkts
Outperform
$125
Oct-14-22 Upgrade
UBS
Sell → Neutral
$86
Sep-19-22 Initiated
Citigroup
Neutral
$90
Jul-20-22 Initiated
UBS
Sell
$86
Jun-17-22 Resumed
JP Morgan
Neutral
$80 → $110
Feb-22-22 Upgrade
Raymond James
Outperform → Strong Buy
$155 → $130
Jan-22-21 Upgrade
Raymond James
Mkt Perform → Outperform
$250
May-12-20 Downgrade
JP Morgan
Neutral → Underweight
$120 → $158
Mar-26-20 Downgrade
Barclays
Overweight → Equal Weight
$90
Oct-23-18 Resumed
Raymond James
Strong Buy
$80
Mar-08-18 Upgrade
Raymond James
Outperform → Strong Buy
Jan-22-18 Reiterated
Barclays
Overweight
$50 → $60
Jan-04-18 Upgrade
CL King
Neutral → Buy
Sep-19-17 Upgrade
Piper Jaffray
Neutral → Overweight
Jul-18-17 Upgrade
William Blair
Mkt Perform → Outperform
Show Previous Ratings
Sep-05-24 05:25PM
Aug-29-24 07:00AM
Aug-19-24 07:00AM
Aug-13-24 04:55PM
Jul-31-24 04:05PM
07:17PM
Loading…
Jul-23-24 07:17PM
Jul-17-24 07:00AM
Jun-26-24 08:52AM
Jun-25-24 06:41AM
Jun-19-24 08:27AM
05:13AM
Jun-07-24 11:30AM
Jun-04-24 05:45AM
May-30-24 06:20AM
May-27-24 04:28AM
07:00AM
Loading…
May-23-24 07:00AM
May-17-24 01:03PM
May-15-24 04:05PM
May-10-24 01:02PM
12:48PM
May-09-24 01:28PM
11:14AM
04:06AM
May-08-24 08:56PM
06:25PM
04:05PM
May-06-24 09:16AM
05:45AM
May-03-24 06:00AM
May-02-24 08:00AM
10:01AM
Loading…
May-01-24 10:01AM
Apr-30-24 08:15PM
Apr-17-24 07:00AM
Apr-12-24 11:47AM
Apr-10-24 07:00AM
Apr-03-24 10:48AM
06:38AM
Apr-02-24 09:00AM
Mar-14-24 07:23AM
Mar-07-24 10:44AM
Mar-06-24 04:35PM
Feb-26-24 04:30PM
Feb-21-24 07:30AM
05:27AM
Feb-20-24 01:49PM
Feb-14-24 08:34PM
10:05AM
09:22AM
Feb-13-24 07:30PM
05:30PM
04:40PM
04:05PM
Feb-12-24 09:16AM
Jan-23-24 07:00AM
Dec-22-23 07:00AM
Dec-20-23 04:05PM
Dec-13-23 05:10AM
Nov-16-23 05:05PM
Nov-01-23 05:56PM
04:05PM
Oct-17-23 03:43PM
Oct-12-23 07:00AM
Sep-21-23 04:05PM
07:02AM
Aug-28-23 04:05PM
Aug-08-23 04:30PM
Jul-25-23 04:00PM
01:12PM
Jul-19-23 08:15AM
Jul-18-23 04:05PM
Jun-21-23 08:00PM
Jun-12-23 11:20AM
May-23-23 07:00AM
May-04-23 07:50AM
(Thomson Reuters StreetEvents) -6.53%
May-03-23 04:05PM
Apr-26-23 08:00PM
Apr-13-23 04:05PM
Mar-28-23 11:05AM
07:54AM
Mar-23-23 12:19PM
Mar-13-23 01:00PM
Mar-08-23 04:05PM
Mar-04-23 09:08AM
08:19AM
Mar-02-23 02:01PM
Feb-27-23 11:00AM
05:13AM
Feb-26-23 08:04AM
Feb-18-23 07:14AM
Feb-16-23 06:18PM
12:07PM
Feb-15-23 04:05PM
Feb-09-23 06:34AM
Jan-24-23 03:25PM
Jan-06-23 04:05PM
Jan-03-23 09:53AM
Dec-28-22 07:00AM
Dec-20-22 06:08PM
09:37AM
Dec-19-22 03:15PM
QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Carlyle Group Inc. 10% Owner Aug 09 '24 Sale 41.53 74,134 3,078,980 8,260,183 Aug 13 04:30 PM Carlyle Group Inc. 10% Owner Aug 08 '24 Sale 41.07 106,705 4,382,446 8,334,317 Aug 09 04:15 PM Carlyle Group Inc. 10% Owner Aug 07 '24 Sale 39.94 78,180 3,122,840 8,441,022 Aug 09 04:15 PM Carlyle Group Inc. 10% Owner Aug 05 '24 Sale 40.37 118,172 4,770,960 8,606,174 Aug 07 04:30 PM Carlyle Group Inc. 10% Owner Aug 06 '24 Sale 40.23 86,972 3,499,160 8,519,202 Aug 07 04:30 PM Carlyle Partners VI Cayman Hol 10% Owner Aug 06 '24 Proposed Sale 42.01 246,775 10,367,018 Aug 05 08:28 PM Carlyle Group Inc. 10% Owner Aug 01 '24 Sale 41.52 234,935 9,753,465 8,893,813 Aug 05 04:30 PM Carlyle Group Inc. 10% Owner Aug 02 '24 Sale 42.10 169,467 7,134,818 8,724,346 Aug 05 04:30 PM Carlyle Group Inc. 10% Owner Jul 31 '24 Sale 39.11 164,877 6,447,760 9,128,748 Aug 01 05:01 PM Carlyle Group Inc. 10% Owner Jul 30 '24 Sale 39.74 150,590 5,985,089 9,293,625 Aug 01 05:01 PM Carlyle Group Inc. 10% Owner Jul 29 '24 Sale 38.85 158,090 6,142,230 9,444,215 Jul 30 04:30 PM Carlyle Group Inc. 10% Owner Jul 26 '24 Sale 39.05 103,926 4,058,307 9,602,305 Jul 30 04:30 PM Carlyle Group Inc. 10% Owner Jul 25 '24 Sale 38.58 406,809 15,696,721 9,706,231 Jul 26 04:30 PM Carlyle Group Inc. 10% Owner Jul 24 '24 Sale 38.97 214,732 8,367,685 10,113,040 Jul 26 04:30 PM Carlyle Group Inc. 10% Owner Jul 22 '24 Sale 35.31 135,241 4,775,665 10,427,317 Jul 24 04:30 PM Carlyle Group Inc. 10% Owner Jul 23 '24 Sale 36.52 99,545 3,635,490 10,327,772 Jul 24 04:30 PM WIDDER KENNETH J Director Jul 19 '24 Option Exercise 27.91 3,333 93,024 28,472 Jul 23 06:43 PM Carlyle Group Inc. 10% Owner Jul 18 '24 Sale 34.13 101,870 3,476,615 10,628,194 Jul 22 04:30 PM Carlyle Group Inc. 10% Owner Jul 19 '24 Sale 34.12 65,636 2,239,738 10,562,558 Jul 22 04:30 PM Carlyle Group Inc. 10% Owner Jul 16 '24 Sale 33.16 94,861 3,145,151 10,799,701 Jul 18 04:30 PM Carlyle Group Inc. 10% Owner Jul 17 '24 Sale 34.81 69,637 2,423,818 10,730,064 Jul 18 04:30 PM Carlyle Group Inc. 10% Owner Jul 15 '24 Sale 31.70 93,187 2,954,302 10,894,562 Jul 16 08:17 PM Carlyle Group Inc. 10% Owner Jul 12 '24 Sale 32.35 57,253 1,852,189 10,987,749 Jul 16 08:17 PM Carlyle Group Inc. 10% Owner Jul 11 '24 Sale 31.37 96,578 3,030,060 11,045,002 Jul 12 04:30 PM Carlyle Group Inc. 10% Owner Jul 10 '24 Sale 30.09 24,390 733,971 11,141,580 Jul 12 04:30 PM Carlyle Group Inc. 10% Owner Jul 08 '24 Sale 30.39 59,973 1,822,715 11,189,751 Jul 10 04:30 PM Carlyle Group Inc. 10% Owner Jul 09 '24 Sale 30.07 23,781 715,109 11,165,970 Jul 10 04:30 PM Carlyle Group Inc. 10% Owner Jul 03 '24 Sale 30.87 52,724 1,627,441 11,300,463 Jul 08 04:30 PM Carlyle Group Inc. 10% Owner Jul 05 '24 Sale 31.15 50,739 1,580,626 11,249,724 Jul 08 04:30 PM Carlyle Group Inc. 10% Owner Jul 02 '24 Sale 31.36 86,454 2,711,095 11,353,187 Jul 03 01:15 PM Carlyle Group Inc. 10% Owner Jul 01 '24 Sale 32.21 81,110 2,612,556 11,439,641 Jul 03 01:15 PM Carlyle Group Inc. 10% Owner Jun 28 '24 Sale 33.05 49,937 1,650,252 11,520,751 Jul 01 04:30 PM Carlyle Group Inc. 10% Owner Jun 27 '24 Sale 33.51 46,380 1,554,398 11,570,688 Jul 01 04:30 PM Carlyle Group Inc. 10% Owner Jun 26 '24 Sale 33.19 81,482 2,704,541 11,617,068 Jun 27 04:30 PM Carlyle Group Inc. 10% Owner Jun 25 '24 Sale 33.01 67,472 2,227,342 11,698,550 Jun 27 04:30 PM Carlyle Group Inc. 10% Owner Jun 24 '24 Sale 34.34 73,713 2,531,371 11,766,022 Jun 25 04:56 PM Carlyle Group Inc. 10% Owner Jun 21 '24 Sale 35.07 68,580 2,404,799 11,839,735 Jun 25 04:56 PM Carlyle Group Inc. 10% Owner Jun 20 '24 Sale 34.89 67,207 2,344,618 11,908,315 Jun 21 04:30 PM Carlyle Group Inc. 10% Owner Jun 18 '24 Sale 35.96 48,541 1,745,606 11,975,522 Jun 21 04:30 PM Carlyle Group Inc. 10% Owner Jun 14 '24 Sale 36.19 127,981 4,631,842 12,123,705 Jun 18 05:46 PM Carlyle Group Inc. 10% Owner Jun 17 '24 Sale 35.99 99,642 3,586,163 12,024,063 Jun 18 05:46 PM Carlyle Group Inc. 10% Owner Jun 13 '24 Sale 37.67 144,234 5,433,190 12,251,686 Jun 14 05:02 PM Carlyle Group Inc. 10% Owner Jun 12 '24 Sale 40.23 64,263 2,585,270 12,395,920 Jun 14 05:02 PM BUECHLER KENNETH F Director Apr 12 '24 Option Exercise 21.07 9,041 190,494 83,679 Apr 16 06:18 PM Busky Joseph M Chief Financial Officer Feb 23 '24 Buy 46.35 2,150 99,663 2,150 Feb 26 06:48 PM
Index RUT
P/E -
EPS (ttm) -5.10
Insider Own 23.38%
Shs Outstand 15.11M
Perf Week -7.27%
Market Cap 281.50M
Forward P/E -
EPS next Y -4.02
Insider Trans -0.05%
Shs Float 11.57M
Perf Month 14.51%
Income -62.44M
PEG -
EPS next Q -1.06
Inst Own 77.42%
Short Float 15.88%
Perf Quarter -26.68%
Sales 0.00M
P/S -
EPS this Y 33.31%
Inst Trans 5.01%
Short Ratio 9.62
Perf Half Y -30.22%
Book/sh 6.64
P/B 2.81
EPS next Y 2.38%
ROA -52.45%
Short Interest 1.84M
Perf Year 86.30%
Cash/sh 7.07
P/C 2.64
EPS next 5Y -
ROE -59.32%
52W Range 4.00 - 31.01
Perf YTD 136.12%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -61.45%
52W High -39.92%
Beta 2.24
Dividend TTM -
Quick Ratio 10.79
Sales past 5Y 0.00%
Gross Margin -
52W Low 365.75%
ATR (14) 1.50
Dividend Ex-Date -
Current Ratio 10.79
EPS Y/Y TTM 48.65%
Oper. Margin 0.00%
RSI (14) 46.35
Volatility 10.93% 7.89%
Employees 45
Debt/Eq 0.02
Sales Y/Y TTM -
Profit Margin -
Recom 1.10
Target Price 71.86
Option/Short Yes / Yes
LT Debt/Eq 0.01
EPS Q/Q 33.91%
Payout -
Rel Volume 0.51
Prev Close 19.15
Sales Surprise -
EPS Surprise 10.89%
Sales Q/Q -
Earnings Aug 13 BMO
Avg Volume 190.95K
Price 18.63
SMA20 -0.95%
SMA50 -5.18%
SMA200 1.27%
Trades
Volume 97,473
Change -2.72%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-08-24 Initiated
BTIG Research
Buy
$90
Jun-27-24 Initiated
Stifel
Buy
$86
May-06-24 Initiated
H.C. Wainwright
Buy
$65
Apr-03-24 Initiated
Evercore ISI
Outperform
$65
Mar-28-24 Initiated
RBC Capital Mkts
Outperform
$70
Mar-18-24 Initiated
TD Cowen
Outperform
Aug-11-23 Initiated
CapitalOne
Overweight
$7
Feb-28-22 Initiated
Cantor Fitzgerald
Overweight
$10
Nov-08-21 Initiated
Credit Suisse
Outperform
$15
Oct-21-21 Initiated
William Blair
Outperform
Oct-20-21 Initiated
BMO Capital Markets
Outperform
$19
Oct-13-21 Initiated
Oppenheimer
Outperform
$21
Show Previous Ratings
Sep-04-24 04:30PM
Aug-13-24 07:00AM
Jun-19-24 08:00AM
Jun-17-24 04:30PM
Jun-14-24 08:00AM
06:05PM
Loading…
May-30-24 06:05PM
May-29-24 04:30PM
May-14-24 01:53PM
08:00AM
May-13-24 08:00AM
May-07-24 04:30PM
12:00PM
Apr-02-24 04:30PM
Mar-22-24 08:50AM
Mar-21-24 04:30PM
08:00AM
Loading…
Mar-19-24 08:00AM
Mar-15-24 08:00AM
Mar-14-24 12:00PM
Mar-06-24 12:53PM
08:50AM
Mar-04-24 07:30AM
Feb-26-24 04:30PM
Feb-23-24 08:00AM
Feb-19-24 08:50AM
Feb-07-24 08:00AM
Feb-06-24 08:59AM
Feb-05-24 08:00AM
Feb-02-24 08:00AM
Jan-24-24 12:14PM
Jan-05-24 08:30AM
08:00AM
Loading…
Jan-02-24 08:00AM
Dec-18-23 04:30PM
Dec-10-23 11:00AM
Nov-30-23 08:00AM
Nov-09-23 09:48AM
08:00AM
Nov-08-23 04:30PM
Nov-02-23 09:00AM
Nov-01-23 08:00AM
Oct-09-23 08:30AM
08:00AM
Sep-25-23 08:00AM
Sep-21-23 08:00AM
Sep-15-23 08:00AM
Aug-11-23 04:05PM
Aug-04-23 04:51PM
Aug-02-23 08:00AM
Jun-22-23 08:00AM
Jun-20-23 08:00AM
Jun-13-23 08:00AM
May-12-23 04:05PM
May-10-23 08:00AM
Apr-13-23 08:00AM
Apr-10-23 04:05PM
Mar-31-23 08:00AM
Mar-23-23 08:00AM
Mar-09-23 08:00AM
Mar-08-23 04:05PM
Feb-17-23 08:20AM
08:10AM
08:00AM
Feb-16-23 04:05PM
Feb-03-23 04:05PM
Jan-30-23 08:00AM
Jan-27-23 01:10PM
Jan-25-23 08:00AM
Jan-24-23 04:25PM
Jan-13-23 08:00AM
Jan-10-23 08:00AM
Jan-04-23 08:00AM
Jan-03-23 08:00AM
Nov-10-22 04:05PM
Sep-26-22 08:00AM
Sep-23-22 08:00AM
Sep-15-22 08:00AM
Aug-12-22 04:05PM
Jun-23-22 04:05PM
(GlobeNewswire) +17.34%
+15.27%
Jun-20-22 10:59AM
Jun-07-22 08:00AM
Jun-06-22 08:00AM
May-27-22 08:00AM
(American City Business Journals)
May-17-22 08:00AM
May-12-22 04:05PM
Apr-28-22 08:00AM
Apr-26-22 04:05PM
Apr-22-22 08:00AM
Mar-31-22 08:00AM
Mar-25-22 07:30PM
Mar-21-22 08:30AM
Mar-18-22 04:05PM
Mar-10-22 08:00AM
Feb-28-22 08:00AM
Feb-24-22 05:19PM
Feb-02-22 01:38PM
Dec-08-21 11:15AM
08:30AM
Nov-20-21 08:21AM
Nov-12-21 04:05PM
Nov-09-21 08:00AM
Nov-08-21 08:00AM
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Mahal Jeetinder Singh Chief Operating Officer Jun 12 '24 Option Exercise 7.10 900 6,390 25,909 Jun 12 09:40 PM Mahal Jeetinder Singh Chief Operating Officer Jun 12 '24 Sale 24.16 900 21,740 25,009 Jun 12 09:40 PM Mahal Jeetinder Singh Chief Operating Officer Mar 12 '24 Option Exercise 7.10 900 6,390 25,909 Mar 12 09:33 PM Mahal Jeetinder Singh Chief Operating Officer Mar 12 '24 Sale 26.44 900 23,792 25,009 Mar 12 09:33 PM Carlyle Group Inc. Former 10% Owner Feb 08 '24 Buy 12.95 190,000 2,460,500 1,066,189 Feb 12 06:23 PM Velan Capital Investment Manag 10% Owner Feb 08 '24 Buy 12.95 350,000 4,532,500 1,188,500 Feb 09 08:40 PM WIGGANS THOMAS G Director Nov 28 '23 Buy 0.65 10,000 6,486 50,000 Nov 30 04:05 PM WIGGANS THOMAS G Director Nov 21 '23 Buy 0.64 10,000 6,383 40,000 Nov 22 04:06 PM WIGGANS THOMAS G Director Nov 20 '23 Buy 0.63 10,000 6,309 30,000 Nov 20 08:14 PM WIGGANS THOMAS G Director Nov 17 '23 Buy 0.60 10,000 5,966 20,000 Nov 20 08:14 PM WIGGANS THOMAS G Director Nov 16 '23 Buy 0.60 10,000 5,965 10,000 Nov 20 08:14 PM Lis William Director Oct 13 '23 Sale 0.85 7,965 6,777 53,521 Oct 13 06:56 PM
Index -
P/E 815.22
EPS (ttm) 0.13
Insider Own 0.55%
Shs Outstand 67.29M
Perf Week -10.89%
Market Cap 7.03B
Forward P/E 13.91
EPS next Y 7.51
Insider Trans -0.76%
Shs Float 66.92M
Perf Month 0.88%
Income 9.00M
PEG 32.01
EPS next Q 1.46
Inst Own 104.18%
Short Float 3.87%
Perf Quarter -19.32%
Sales 3.58B
P/S 1.96
EPS this Y 27.28%
Inst Trans 9.09%
Short Ratio 2.72
Perf Half Y -21.69%
Book/sh 33.18
P/B 3.15
EPS next Y 33.14%
ROA 0.10%
Short Interest 2.59M
Perf Year 6.67%
Cash/sh 12.65
P/C 8.26
EPS next 5Y 25.46%
ROE 0.38%
52W Range 63.44 - 147.40
Perf YTD 1.52%
Dividend Est. 0.88 (0.84%)
P/FCF 17.97
EPS past 5Y -
ROI 0.12%
52W High -29.15%
Beta 1.64
Dividend TTM 0.88 (0.84%)
Quick Ratio 2.31
Sales past 5Y 12.63%
Gross Margin 39.30%
52W Low 64.61%
ATR (14) 5.45
Dividend Ex-Date Aug 26, 2024
Current Ratio 3.58
EPS Y/Y TTM 100.50%
Oper. Margin 13.18%
RSI (14) 37.12
Volatility 4.75% 4.02%
Employees 10200
Debt/Eq 2.29
Sales Y/Y TTM -6.67%
Profit Margin 0.25%
Recom 1.73
Target Price 141.00
Option/Short Yes / Yes
LT Debt/Eq 2.25
EPS Q/Q 101.29%
Payout -
Rel Volume 1.29
Prev Close 108.50
Sales Surprise 2.38%
EPS Surprise 46.17%
Sales Q/Q -11.57%
Earnings Aug 07 AMC
Avg Volume 950.22K
Price 104.43
SMA20 -9.48%
SMA50 -14.93%
SMA200 -10.57%
Trades
Volume 1,228,034
Change -3.75%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-03-24 Initiated
Goldman
Neutral
$129
Aug-05-24 Initiated
Morgan Stanley
Overweight
$155
Jul-10-24 Initiated
BofA Securities
Buy
$160
Jun-20-24 Resumed
Deutsche Bank
Hold
$140
Mar-01-23 Upgrade
The Benchmark Company
Hold → Buy
$125
Dec-20-22 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
$100
Nov-04-22 Downgrade
The Benchmark Company
Buy → Hold
Feb-23-22 Initiated
Loop Capital
Buy
$200
Jan-26-22 Initiated
KeyBanc Capital Markets
Sector Weight
Dec-27-21 Reiterated
Needham
Buy
$215
Dec-13-21 Upgrade
Citigroup
Neutral → Buy
$190
Oct-29-21 Resumed
Rosenblatt
Buy
Aug-20-21 Resumed
Citigroup
Neutral
$160
Jul-06-21 Resumed
Deutsche Bank
Buy
$225
Dec-11-20 Reiterated
Cowen
Outperform
$150 → $178
Sep-11-20 Initiated
Berenberg
Buy
Jul-28-20 Reiterated
Needham
Buy
$125 → $135
Jul-22-20 Initiated
Rosenblatt
Buy
$162
Jun-25-20 Initiated
Wells Fargo
Equal Weight
$120
Jun-18-20 Upgrade
DA Davidson
Neutral → Buy
$150
Show Previous Ratings
Sep-06-24 11:31AM
Sep-04-24 09:50AM
Aug-21-24 09:00AM
Aug-13-24 09:00AM
Aug-08-24 11:51PM
(Thomson Reuters StreetEvents) +6.23%
08:49AM
Loading…
08:49AM
Aug-07-24 07:50PM
06:55PM
(Associated Press Finance)
04:30PM
Aug-06-24 09:40AM
09:00AM
Aug-05-24 09:45AM
Aug-01-24 01:37PM
12:45PM
Jul-31-24 10:01AM
09:00AM
Loading…
Jul-29-24 09:00AM
Jul-23-24 12:10PM
09:00AM
Jul-19-24 09:45AM
Jul-16-24 12:45PM
12:00PM
Jul-15-24 08:00AM
Jun-19-24 09:50AM
Jun-18-24 09:00AM
Jun-14-24 02:18AM
Jun-10-24 09:00AM
Jun-07-24 11:30AM
Jun-06-24 03:11PM
May-23-24 08:00AM
May-16-24 04:57PM
04:15PM
Loading…
04:15PM
May-14-24 09:00AM
04:59AM
May-13-24 11:01PM
02:25PM
09:49AM
06:37AM
May-10-24 12:30PM
10:35AM
May-09-24 10:40PM
(Thomson Reuters StreetEvents)
10:59AM
May-08-24 06:15PM
05:32PM
05:14PM
(Associated Press Finance)
04:30PM
09:00AM
May-06-24 09:00AM
May-04-24 07:38AM
Apr-15-24 08:00AM
Mar-08-24 11:30AM
Mar-04-24 01:00PM
Feb-29-24 01:57AM
Feb-28-24 04:00PM
Feb-26-24 01:00PM
Feb-09-24 09:01AM
Feb-08-24 09:57PM
(Thomson Reuters StreetEvents) +5.62%
10:30AM
Feb-07-24 05:12PM
(Associated Press Finance)
04:57PM
04:30PM
Feb-06-24 09:00AM
Jan-30-24 09:00AM
Jan-25-24 09:00AM
Jan-24-24 04:30PM
Jan-23-24 08:00AM
Jan-22-24 04:10PM
Jan-08-24 09:00AM
Dec-20-23 09:00AM
Dec-07-23 09:00AM
Dec-04-23 07:00AM
Dec-01-23 11:31AM
05:40AM
Nov-23-23 05:08AM
Nov-07-23 09:00AM
Nov-03-23 03:32PM
Nov-01-23 06:17PM
(Associated Press Finance)
04:30PM
Oct-20-23 09:00AM
Oct-18-23 05:49AM
Oct-10-23 09:00AM
Oct-06-23 12:00PM
Oct-03-23 04:30PM
Sep-28-23 09:00AM
Sep-08-23 08:58AM
Sep-07-23 12:18PM
Sep-01-23 11:31AM
Aug-28-23 09:00AM
Aug-13-23 09:14AM
Aug-08-23 09:00AM
Aug-03-23 10:26PM
(Thomson Reuters StreetEvents)
11:26AM
Aug-02-23 07:35PM
06:32PM
04:30PM
Jul-21-23 09:00AM
Jul-18-23 09:00AM
Jul-13-23 02:56PM
Jun-21-23 08:00PM
Jun-11-23 09:29AM
Jun-01-23 08:10PM
MKS Instruments, Inc. provides instruments, systems, subsystems and process control solutions to measure, control, power, monitor, and analyze parameters of manufacturing processes to improve process performance and productivity for its customers. It operates through the following segments: Vacuum & Analysis, Light & Motion and Equipment & Solutions. The Vacuum & Analysis segment comprises pressure measurement and control, flow measurement and control, gas and vapor delivery, gas composition analysis, residual gas analysis, leak detection, control technology, ozone generation and delivery, RF & DC power, reactive gas generation and vacuum technology components. The Light & Motion segment includes lasers, photonics, sub-micron positioning, vibration control, and optics instruments. The Equipment & Solutions segment provides laser-based manufacturing systems solutions for the micro-machining industry that enable customers to optimize production. The company was founded in 1961 and is headquartered in Andover, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Mora Elizabeth Director Sep 03 '24 Sale 115.97 275 31,892 17,934 Sep 04 01:28 PM Mora Elizabeth Director Sep 03 '24 Proposed Sale 115.97 275 31,892 Sep 03 09:47 AM Williams John Edward EVP & GM, PSD Aug 16 '24 Sale 118.71 1,800 213,678 13 Aug 19 11:59 AM Williams John Edward Officer Aug 16 '24 Proposed Sale 118.71 1,800 213,678 Aug 16 01:00 PM Moloney Jacqueline F Director Aug 01 '24 Sale 123.46 250 30,865 10,533 Aug 02 12:13 PM Moloney Jacqueline F Director Aug 01 '24 Proposed Sale 123.46 250 30,865 Aug 01 02:56 PM Mora Elizabeth Director Jun 03 '24 Sale 129.41 275 35,588 18,209 Jun 04 01:45 PM Mora Elizabeth Director Apr 01 '24 Sale 133.00 250 33,250 16,862 Apr 02 11:36 AM Moloney Jacqueline F Director Mar 01 '24 Sale 122.89 250 30,722 9,161 Mar 04 11:43 AM Burke Kathleen Flaherty EVP, GC & Secretary Mar 01 '24 Sale 122.89 7,411 910,738 42,999 Mar 04 11:39 AM BAGSHAW SETH H EVP, CFO & Treasurer Feb 22 '24 Sale 123.28 32,865 4,051,629 1 Feb 26 11:51 AM Moloney Jacqueline F Director Feb 16 '24 Sale 124.10 1,917 237,933 9,411 Feb 20 03:21 PM COLELLA GERARD G Director Feb 09 '24 Sale 120.00 10,000 1,200,003 68,017 Feb 12 12:21 PM COLELLA GERARD G Director Jan 22 '24 Sale 110.00 10,000 1,100,004 78,017 Jan 23 01:45 PM Mora Elizabeth Director Jan 02 '24 Sale 100.90 250 25,225 17,112 Jan 03 01:54 PM Moloney Jacqueline F Director Dec 01 '23 Sale 82.23 250 20,558 11,328 Dec 04 10:17 AM Henry David Philip EVP, Operations & Corp Mktg Nov 07 '23 Buy 68.34 2,500 170,862 11,073 Nov 08 11:40 AM Mora Elizabeth Director Oct 02 '23 Sale 87.15 250 21,788 17,362 Oct 03 02:34 PM
Index RUT
P/E -
EPS (ttm) -2.20
Insider Own 24.24%
Shs Outstand 44.45M
Perf Week 1.14%
Market Cap 2.04B
Forward P/E -
EPS next Y -2.84
Insider Trans -7.32%
Shs Float 41.54M
Perf Month 4.35%
Income -107.85M
PEG -
EPS next Q -0.67
Inst Own 90.09%
Short Float 14.64%
Perf Quarter -2.16%
Sales 0.00M
P/S -
EPS this Y -13.82%
Inst Trans 1.75%
Short Ratio 10.96
Perf Half Y -14.09%
Book/sh 5.98
P/B 6.22
EPS next Y -10.75%
ROA -36.41%
Short Interest 6.08M
Perf Year 98.72%
Cash/sh 7.01
P/C 5.31
EPS next 5Y -
ROE -46.05%
52W Range 9.24 - 50.78
Perf YTD 141.87%
Dividend Est. -
P/FCF -
EPS past 5Y 10.22%
ROI -28.49%
52W High -26.74%
Beta 1.00
Dividend TTM -
Quick Ratio 21.15
Sales past 5Y 0.00%
Gross Margin -
52W Low 302.60%
ATR (14) 1.92
Dividend Ex-Date -
Current Ratio 21.15
EPS Y/Y TTM 33.79%
Oper. Margin 0.00%
RSI (14) 47.61
Volatility 5.35% 4.97%
Employees 51
Debt/Eq 0.16
Sales Y/Y TTM -
Profit Margin -
Recom 1.22
Target Price 61.33
Option/Short Yes / Yes
LT Debt/Eq 0.15
EPS Q/Q -35.24%
Payout -
Rel Volume 0.59
Prev Close 38.16
Sales Surprise -
EPS Surprise -10.71%
Sales Q/Q -
Earnings Aug 08 BMO
Avg Volume 554.84K
Price 37.20
SMA20 -1.97%
SMA50 1.38%
SMA200 9.09%
Trades
Volume 327,060
Change -2.52%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-25-24 Initiated
Oppenheimer
Outperform
$26
Jan-08-24 Initiated
Cantor Fitzgerald
Overweight
Dec-18-23 Initiated
Raymond James
Outperform
$29
Nov-10-23 Upgrade
Jefferies
Hold → Buy
$18 → $26
Aug-16-23 Initiated
Guggenheim
Buy
$27
Jan-04-23 Downgrade
Wedbush
Outperform → Neutral
$33 → $8
Jan-04-23 Downgrade
Jefferies
Buy → Hold
$32 → $6
Jul-12-22 Initiated
JP Morgan
Overweight
$35
May-02-22 Initiated
H.C. Wainwright
Buy
$35
Apr-19-22 Initiated
Wedbush
Outperform
$32
Sep-05-24 01:07AM
Sep-03-24 08:27AM
08:27AM
07:49AM
Sep-02-24 06:05PM
08:00AM
Loading…
Aug-29-24 08:00AM
Aug-09-24 04:05PM
Aug-08-24 08:00AM
Jul-05-24 04:30PM
Jul-01-24 08:00AM
Jun-11-24 04:01PM
Jun-07-24 04:05PM
04:05PM
May-28-24 08:00AM
May-25-24 09:40AM
04:27PM
Loading…
May-17-24 04:27PM
May-10-24 05:38AM
May-09-24 01:53PM
08:00AM
May-07-24 04:38PM
Apr-23-24 05:09PM
(The Wall Street Journal)
Apr-13-24 05:29AM
Apr-12-24 07:01PM
Apr-11-24 04:29PM
(Yahoo Finance Video) +17.30%
Apr-05-24 06:30PM
Apr-02-24 08:00AM
Mar-20-24 12:52PM
07:30AM
Feb-28-24 04:20PM
Feb-02-24 12:40PM
08:00AM
Loading…
08:00AM
Feb-01-24 04:05PM
Jan-29-24 11:50PM
06:15AM
Jan-25-24 06:30AM
Jan-12-24 06:44PM
Jan-08-24 08:01AM
08:00AM
Dec-27-23 08:00AM
Dec-15-23 10:15AM
Nov-14-23 05:05PM
09:55AM
Nov-09-23 09:29AM
08:00AM
Nov-04-23 10:00AM
Oct-30-23 08:00AM
Oct-18-23 09:35AM
Oct-17-23 09:35AM
Oct-16-23 09:35AM
Oct-13-23 10:22AM
Sep-26-23 04:02PM
Aug-31-23 08:00AM
Aug-16-23 10:00AM
Aug-15-23 04:03PM
Aug-10-23 08:00AM
Aug-04-23 06:30PM
Jul-24-23 09:01AM
Jul-07-23 06:35PM
Jun-27-23 08:05AM
Jun-20-23 07:04PM
09:33AM
Jun-17-23 10:10AM
Jun-15-23 04:44PM
Jun-12-23 12:05PM
Jun-11-23 01:08PM
Jun-08-23 08:00AM
Jun-07-23 08:00AM
May-11-23 08:36AM
07:30AM
May-04-23 08:00AM
Mar-28-23 07:30AM
Feb-27-23 04:05PM
Feb-14-23 07:48AM
Feb-09-23 06:51AM
05:54AM
Feb-06-23 04:05PM
Feb-01-23 09:52PM
04:01PM
Jan-30-23 07:35AM
06:00AM
Jan-25-23 08:00AM
Jan-22-23 07:39AM
Jan-06-23 05:02AM
Jan-04-23 04:07PM
(Investor's Business Daily) -64.70%
-13.31%
12:20PM
10:22AM
06:52AM
Jan-03-23 04:01PM
Dec-20-22 04:05PM
Nov-25-22 07:38AM
Nov-22-22 07:30AM
Nov-17-22 07:30AM
Nov-09-22 07:30AM
Nov-05-22 04:50PM
Oct-17-22 07:30AM
Sep-15-22 09:55AM
Sep-07-22 07:30AM
Aug-29-22 09:55AM
Aug-12-22 09:55AM
Aug-10-22 07:30AM
Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Fordyce Marshall PRESIDENT AND CEO Aug 28 '24 Option Exercise 2.90 15,625 45,262 337,592 Aug 30 04:04 PM Fordyce Marshall PRESIDENT AND CEO Aug 28 '24 Sale 36.84 30,320 1,117,140 307,972 Aug 30 04:04 PM MARSHALL FORDYCE Director Aug 28 '24 Proposed Sale 37.65 30,320 1,141,548 Aug 28 04:15 PM Fordyce Marshall PRESIDENT AND CEO Aug 21 '24 Sale 39.76 14,471 575,425 322,667 Aug 23 05:40 PM Fordyce Marshall PRESIDENT AND CEO Aug 14 '24 Option Exercise 2.90 15,625 45,262 352,763 Aug 16 04:31 PM Fordyce Marshall PRESIDENT AND CEO Aug 14 '24 Sale 37.56 15,625 586,927 337,138 Aug 16 04:31 PM MARSHALL FORDYCE Director Aug 14 '24 Proposed Sale 37.95 15,625 592,969 Aug 14 04:24 PM Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR May 16 '24 Option Exercise 7.87 20,651 162,523 69,357 May 17 04:21 PM Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR May 15 '24 Option Exercise 3.94 8,221 32,387 61,392 May 17 04:21 PM Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR May 16 '24 Sale 42.32 20,651 873,890 51,206 May 17 04:21 PM Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR May 15 '24 Sale 42.27 10,186 430,546 51,206 May 17 04:21 PM Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR Apr 10 '24 Sale 40.00 5,714 228,560 53,171 Apr 12 04:02 PM Grant Sean CHIEF FINANCIAL OFFICER Apr 03 '24 Option Exercise 14.87 99,828 1,484,442 166,165 Apr 05 09:32 PM Grant Sean CHIEF FINANCIAL OFFICER Apr 03 '24 Sale 39.61 99,828 3,954,516 66,337 Apr 05 09:32 PM Grant Sean CHIEF FINANCIAL OFFICER Apr 03 '24 Sale 39.42 18,649 735,205 0 Apr 05 09:32 PM Katabi Maha Director Mar 22 '24 Sale 40.51 413,450 16,748,860 3,133,987 Mar 25 09:46 PM Katabi Maha Director Mar 25 '24 Sale 40.50 340,000 13,770,000 2,793,987 Mar 25 09:46 PM Katabi Maha Director Mar 21 '24 Sale 44.20 81,009 3,580,723 3,547,437 Mar 25 09:46 PM Katabi Maha Director Jan 30 '24 Buy 31.00 161,290 4,999,990 3,628,446 Feb 01 05:58 PM COMMODORE CAPITAL LP 10% Owner Jan 10 '24 Sale 18.00 1,050,000 18,900,000 4,400,000 Jan 12 09:55 PM Fordyce Marshall President and CEO Dec 29 '23 Option Exercise 2.87 13,516 38,854 256,877 Jan 03 04:15 PM
Index -
P/E 266.02
EPS (ttm) 0.04
Insider Own 20.54%
Shs Outstand 384.83M
Perf Week -1.85%
Market Cap 3.49B
Forward P/E 9.90
EPS next Y 0.96
Insider Trans 2.01%
Shs Float 290.26M
Perf Month 9.77%
Income 15.40M
PEG 40.68
EPS next Q 0.22
Inst Own 78.56%
Short Float 9.12%
Perf Quarter -22.80%
Sales 1.23B
P/S 2.83
EPS this Y -13.11%
Inst Trans -3.93%
Short Ratio 3.65
Perf Half Y -42.37%
Book/sh 5.08
P/B 1.88
EPS next Y 9.90%
ROA 0.22%
Short Interest 26.48M
Perf Year -46.56%
Cash/sh 1.09
P/C 8.74
EPS next 5Y 6.54%
ROE 0.73%
52W Range 7.65 - 19.39
Perf YTD -48.35%
Dividend Est. -
P/FCF 8.49
EPS past 5Y -
ROI 0.47%
52W High -50.75%
Beta 1.03
Dividend TTM -
Quick Ratio 0.97
Sales past 5Y 56.47%
Gross Margin 83.74%
52W Low 24.84%
ATR (14) 0.42
Dividend Ex-Date -
Current Ratio 0.97
EPS Y/Y TTM -88.28%
Oper. Margin 13.18%
RSI (14) 43.41
Volatility 3.29% 4.19%
Employees 3516
Debt/Eq 0.76
Sales Y/Y TTM 2.77%
Profit Margin 1.25%
Recom 2.64
Target Price 11.08
Option/Short Yes / Yes
LT Debt/Eq 0.75
EPS Q/Q -169.30%
Payout 0.00%
Rel Volume 0.77
Prev Close 9.94
Sales Surprise -5.00%
EPS Surprise -28.09%
Sales Q/Q -5.54%
Earnings Aug 05 AMC
Avg Volume 7.25M
Price 9.55
SMA20 0.61%
SMA50 -10.63%
SMA200 -32.77%
Trades
Volume 5,569,831
Change -3.92%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-13-24 Downgrade
Daiwa Securities
Outperform → Neutral
$15 → $9
Aug-06-24 Downgrade
Raymond James
Outperform → Mkt Perform
Aug-06-24 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Aug-06-24 Downgrade
DA Davidson
Buy → Neutral
$20 → $9.50
Aug-06-24 Downgrade
BofA Securities
Buy → Underperform
$23 → $8
May-08-24 Downgrade
Piper Sandler
Overweight → Neutral
$24 → $15
May-08-24 Downgrade
Mizuho
Buy → Neutral
$23 → $14
May-08-24 Downgrade
Goldman
Neutral → Sell
$19.50 → $12
Mar-21-24 Initiated
KeyBanc Capital Markets
Overweight
$20
Feb-08-24 Downgrade
Citigroup
Neutral → Sell
$20 → $13
Feb-07-24 Initiated
Jefferies
Buy
$20
Feb-01-24 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$24 → $20
Jan-29-24 Upgrade
BofA Securities
Neutral → Buy
$20 → $25
Jan-12-24 Downgrade
Barclays
Overweight → Equal Weight
$18
Jan-08-24 Downgrade
RBC Capital Mkts
Sector Perform → Underperform
$16 → $14
Nov-01-23 Downgrade
Goldman
Buy → Neutral
$30 → $17
Sep-05-23 Initiated
Citigroup
Neutral
$19
Aug-02-23 Downgrade
Wolfe Research
Outperform → Peer Perform
Aug-01-23 Downgrade
Deutsche Bank
Buy → Hold
$20
Jul-24-23 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$30 → $28
Show Previous Ratings
Sep-04-24 04:32PM
Aug-14-24 09:00AM
Aug-13-24 09:00AM
Aug-07-24 09:00AM
09:00AM
04:17PM
Loading…
Aug-06-24 04:17PM
01:56PM
12:35PM
12:29PM
(Associated Press Finance)
10:34AM
(The Wall Street Journal)
09:35AM
09:25AM
(Thomson Reuters StreetEvents)
04:32AM
Aug-05-24 10:15PM
05:20PM
04:41PM
Loading…
04:41PM
04:22PM
(Associated Press Finance)
04:06PM
04:05PM
04:05PM
Aug-04-24 03:02AM
Jul-26-24 04:02AM
Jul-25-24 01:17PM
03:39AM
Jul-18-24 09:00AM
Jul-08-24 03:43AM
Jul-02-24 04:30PM
Jun-24-24 06:02PM
04:29PM
09:00AM
06:16AM
Loading…
Jun-20-24 06:16AM
Jun-05-24 09:30AM
May-22-24 09:00AM
May-16-24 05:23PM
May-13-24 09:00AM
May-10-24 06:47PM
May-09-24 09:00AM
May-08-24 12:55PM
12:22PM
11:56AM
11:27AM
10:32AM
10:26AM
10:22AM
09:34AM
08:57AM
08:14AM
(Thomson Reuters StreetEvents)
08:03AM
07:31AM
06:47AM
06:45AM
06:45AM
May-07-24 10:30PM
05:48PM
05:38PM
05:15PM
04:27PM
04:15PM
(Associated Press Finance)
04:05PM
May-06-24 03:07AM
Apr-15-24 12:00PM
09:00AM
Apr-10-24 09:00AM
Apr-09-24 09:00AM
07:00AM
Apr-02-24 04:30AM
Apr-01-24 07:22AM
Mar-13-24 12:04PM
Mar-05-24 05:28AM
Feb-26-24 05:45PM
Feb-20-24 09:00AM
Feb-15-24 05:00PM
Feb-13-24 08:03PM
04:24PM
01:14PM
01:14PM
01:13PM
12:44PM
10:08AM
08:55AM
(Thomson Reuters StreetEvents)
08:46AM
Feb-12-24 09:15PM
05:44PM
05:15PM
04:38PM
04:26PM
(Associated Press Finance)
04:13PM
04:05PM
Feb-11-24 02:00AM
Feb-09-24 12:10PM
Feb-06-24 09:00AM
Jan-29-24 07:14PM
02:44PM
10:57AM
Jan-26-24 06:15AM
Jan-16-24 09:00AM
02:39AM
Jan-15-24 01:30AM
Jan-08-24 10:06AM
Dec-21-23 05:00PM
ZoomInfo Technologies, Inc. is a holding company, which engages in the provision of a cloud-based platform that offers information on organizations and professionals for sales and marketing teams. It offers sales leadership, sales development, marketing, and demand generation, sales and marketing operations, and recruiting. The company was founded by Henry L. Schuck and Kirk N. Brown in 2007 and is headquartered in Vancouver, WA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
ALI DASDAN Officer Sep 06 '24 Proposed Sale 9.94 4,898 48,686 Sep 06 04:19 PM Schuck Henry Chief Executive Officer Aug 07 '24 Buy 8.49 1,500,000 12,736,650 11,788,001 Aug 09 04:41 PM Hyzer Peter Cameron Chief Financial Officer Jul 09 '24 Sale 12.37 7,500 92,775 1,316,518 Jul 11 04:38 PM Hyzer Peter Cameron Chief Financial Officer Jun 13 '24 Sale 12.78 7,500 95,850 1,279,023 Jun 17 04:15 PM MADER MARK PATRICK Director Jun 13 '24 Sale 12.78 3,112 39,771 17,622 Jun 17 04:15 PM Dasdan Ali Chief Technology Officer Jun 04 '24 Sale 11.90 5,862 69,744 87,540 Jun 04 07:01 PM Dasdan Ali Chief Technology Officer Mar 04 '24 Sale 16.56 6,334 104,916 69,954 Mar 05 04:45 PM Dasdan Ali Chief Technology Officer Dec 04 '23 Sale 14.69 5,007 73,577 50,953 Dec 05 04:57 PM Dasdan Ali Chief Technology Officer Sep 14 '23 Sale 17.27 11,977 206,800 35,929 Sep 18 04:26 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite